Chronic low-dose As exposure can downregulate adiponectin mRNA expression, increase fasting fat production, and promote plasma TG levels, thereby eventually leading to the development of dyslipidemia [33, 34]. The gene discussed is ADIPOQ; the disease is metabolic syndrome.